Protocol for Stereotactic Body Radiation Therapy: Applications in Oligometastases, Radiation Oncology, CT-Simulation, Immobilisation, and Process Quality Control
Keywords:
Stereotactic Body Radiation Therapy, Radiation Oncology, CT-Simulation, Immobilisation, Quality ControlAbstract
: In a small number of fractions, stereotactic body radiation therapy (SBRT) applies extremely high and conformal radiation doses to clearly defined targets in the chest, abdomen, or paraspinal regions. These doses are not homogeneous and have small or no margins, which makes them ideal for treating potentially heterogeneous and physiologically moving targets. A comprehensive evaluation of objectives and resource allocation is necessary before embarking on SBRT, which demands a substantial investment of staff and equipment. The SBRT delivery system is designed to integrate and regulate all treatment phases to the highest degree feasible, ensuring accurate SBRT delivery. For assistance on how to implement each phase of SBRT, there are a variety of resources available, including as reports from the American Association of Physicists in Medicine (AAPM) Task Group, practice recommendations from the American College of Radiology (ACR), and white papers from the American Society for Radiation Oncology (ASTRO). Imaging to define the target, immobilisation, simulation, planning, motion control, alignment imaging, and beam delivery are the phases. Following the quality assurance program's guidelines, qualified staff apply the necessary equipment at each stage of the treatment delivery process utilising procedures created during deployment. Planning, allocating resources (including human and material), providing training, developing protocols, and conducting continuing quality assurance (QA) at every stage of treatment delivery are all necessary for an SBRT programme to be successfully implemented. Imaging, simulation, planning, motion management, image-guidance, and treatment administration are all parts of SBRT that can be aided by well-established tools. A good SBRT programme can be achieved by understanding and following that guidelines.
Downloads
References
Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B et al. (2010) Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys 37(8):4078 1 Jan 2010
Bezjak A, Bradley J, Gaspar L, Timmerman RD, Papiez L, Gore E et al. (2012) RTOG 0813 seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non small cell lung cancer (NSCLC) in medically inoperable patients, pp 1–81
Bissonnette J-P, Balter PA, Dong L, Langen KM, Lovelock DM, Miften M et al (2012) Quality assurance for imageguided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys 39(4):1946
Feuvret L, Noel G, Mazeron J, Bey P (2006) Conformity index: a review. Int J Radiat Oncol Biol Phys 64(2):333–342
Fraass B, Doppke K, Hunt M, Kutcher G, Starkschall G, Stern R et al. (1998) American association of physicists in medicine radiation therapy committee task group 53: quality assurance for clinical radiotherapy treatment planning. Med Phys pp 1773–1829
Kissick MW, Mackie TR (2009) Task group 76 report on ‘‘the management of respiratory motion in radiation oncology’’. Med Phys 36(12): 5721–5722
Klein EE, Hanley J, Bayouth J, Yin F–F, Simon W, Dresser S et al. (2009) Task Group 142 report: quality assurance of medical accelerators. Med Phys pp 4197–4212
Mutic S, Palta JR, Butker EK, Das IJ, Huq MS, Loo L-ND et al (2003) Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM radiation therapy committee Task Group No. 66. Med Phys 30(10):2762
Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA et al (2010) American society for therapeutic radiology and oncology (Astro) and American College of Radiology (Acr) Practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76(2):326–332
Ryu S, Gerszten P, Yin F–F, Timmerman RD, Dicker A, Movsas B et al (2012) RTOG 0631 phase II/III study of image-guided radiosurgery/SBRT for localized spine metastasis. Radiat Therapy Oncol Group 3:1–65
Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C et al. (2012a) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary. Supplementary material. PRO 2(1):Supplemental pp 1–49
Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C et al. (2012b) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary. PRO 2(1):2–9
Timmerman RD, Galvin J, Gore E, Bae K, Pass H, Edelman MJ, et al. RTOG 0618 A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer. 17 May 2007:1–66
Videtic GMM, Singh AK, Chang JY, Le Q-T, Parker W, Olivier KR, Schild SE, Bae K (2010) RTOG 0915 (NCCTG N0927) A randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage 1 peripheral nonsmall cell lung cancer, pp 1–66
Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378 –382.
Rubin P, Brasacchio R, Katz A. Solitary metastases: Illusion versus reality. Semin Radiat Oncol 2006;16: 120 –130.
Yu CX, Amies CJ, Svatos M. Planning and delivery of intensity-modulated radiation therapy. Med Phys 2008;35:5233–5241.
Welsh JS. Basics of particle therapy: Introduction to hadrons. Am J Clin Oncol 2008;31:493– 495.
Onimaru R, Shirato H, Shimizu S et al. Tolerance of organs at risk in small volume, hypofractionated, imageguided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126 –135.
Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398 – 403.
Nagata Y, Wulf J, Lax I et al. Stereotactic radiotherapy of primary lung cancer and other targets: Results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011;79:660 – 669.
Boda-Heggemann J, Lohr F, Wenz F et al. kV conebeam CT-based IGRT: A clinical review. Strahlenther Onkol 2011;187:284 –291.
Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Am J Clin Oncol 2007;30:637– 644.
Lo SS, Cardenes HR, Teh BS et al. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev Anticancer Ther 2008;8:1939 – 1951.
Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005;8:89 – 91.
Hall EJ, Brenner DJ. The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 1993;25:381–385.
Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: A systematic review. J Thorac Oncol 2010;5:1091–1099.
Rusthoven KE, Kavanagh BD, Burri SH et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27:1579 –1584.
Lax I, Blomgren H, Larson D et al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg 1998;1:135–148.
Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861– 870.
Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer 2012;75:77– 81.
Okunieff P, Petersen AL, Philip A et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006;45:808 – 817.
The International Registry of Lung Metastases. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37– 49.
Lencioni R, Crocetti L, Cioni R et al. Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621– 628.
Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: A novel treatment modality. Nat Rev Clin Oncol 2010;7:44 –54.
Scorsetti M, Bignardi M, Alongi F et al. Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results. Acta Oncol 2011;50:528 –538.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Current Clinical and Medical Education
